Dr. Dai Chu Luu, MD
What this data tells you about Dr. Luu
Dr. Dai Chu Luu is a student in an organized health care education/training program in Dallas, TX, with 15 years in practice. Based on federal Medicare data, Dr. Luu performed 82,935 Medicare services across 2,907 unique beneficiaries.
Between the years covered by Open Payments, Dr. Luu received a total of $86,973 from 62 pharmaceutical and/or device companies across 320 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in student in an organized health care education/training program. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Luu is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Darbepoetin injection (Aranesp) for anemia | 14,715 | $2 | $20 |
| Anti-nausea injection (fosaprepitant) | 13,830 | $0 | $5 |
| Iron sucrose injection (Venofer) | 13,500 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 10,800 | $43 | $137 |
| Oxaliplatin chemotherapy injection | 7,550 | $0 | $33 |
| Daratumumab injection (Darzalex) | 5,760 | $38 | $127 |
| Paclitaxel chemotherapy injection | 4,658 | $0 | $8 |
| Dexamethasone injection (steroid) | 1,701 | $0 | $1 |
| Immune globulin infusion (Octagam) | 1,320 | $34 | $234 |
| Anti-nausea injection (Aloxi/palonosetron) | 1,240 | $1 | $114 |
| Injection, granisetron hydrochloride, 100 mcg | 1,100 | $0 | $24 |
| Injection, atropine sulfate, 0.01 mg | 720 | $0 | $1 |
| Blood draw (venipuncture) | 656 | $8 | $20 |
| Complete blood count (CBC) with differential | 548 | $8 | $36 |
| Office visit, established patient (30-39 min) | 398 | $91 | $368 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 358 | $23 | $157 |
| Administration of chemotherapy into vein, 1 hour or less | 357 | $101 | $707 |
| Comprehensive metabolic blood panel | 292 | $10 | $64 |
| Injection, fluorouracil, 500 mg | 260 | $2 | $13 |
| Injection, carboplatin, 50 mg | 237 | $2 | $300 |
| Basic metabolic blood panel | 225 | $8 | $49 |
| Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 216 | $76 | $1,348 |
| Injection, zoledronic acid, 1 mg | 201 | $6 | $431 |
| Drug injection, under skin or into muscle | 168 | $11 | $96 |
| Ferritin level test (iron stores) | 167 | $13 | $60 |
| Injection of additional new drug or substance into vein | 160 | $12 | $108 |
| Iron level test | 154 | $6 | $27 |
| Iron binding capacity test | 154 | $9 | $35 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 140 | $48 | $313 |
| Office visit, established patient, complex (40-54 min) | 140 | $131 | $496 |
| Infusion, normal saline solution , 1000 cc | 128 | $2 | $19 |
| Injection, diphenhydramine hcl, up to 50 mg | 109 | $1 | $7 |
| Immunoglobulin level test | 93 | $9 | $56 |
| Administration of additional new drug or substance into vein, 1 hour or less | 91 | $51 | $344 |
| Administration of chemotherapy into vein, each additional hour | 73 | $22 | $161 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 66 | $57 | $211 |
| Unclassified drugs | 60 | $1 | $8 |
| Measurement of immunoglobulin light chains | 54 | $17 | $60 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 47 | $16 | $100 |
| Microscopic examination for white blood cells with manual cell count | 46 | $4 | $22 |
| Complete blood count (CBC), automated | 46 | $6 | $34 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 44 | $1 | $19 |
| Infusion into a vein for hydration, 31-60 minutes | 43 | $26 | $256 |
| Hospital follow-up visit, moderate complexity | 42 | $62 | $247 |
| Infusion into a vein for hydration, each additional hour | 30 | $10 | $75 |
| Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l | 28 | $135 | $500 |
| Irrigation of implanted venous access drug delivery device | 27 | $16 | $114 |
| Office visit, established patient (20-29 min) | 26 | $59 | $250 |
| Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle | 24 | $27 | $145 |
| Hospital follow-up visit, high complexity | 22 | $92 | $357 |
| Injection, lorazepam, 2 mg | 22 | $1 | $3 |
| New patient office visit, complex (60-74 min) | 21 | $168 | $709 |
| Administration of additional new drug or substance into vein using push technique | 19 | $44 | $289 |
| Application of on-body injector for under skin injection | 17 | $15 | $96 |
| New patient office visit (45-59 min) | 17 | $112 | $565 |
| Initial hospital admission, high complexity | 15 | $136 | $694 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (65%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in student in an organized health care education/training program and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 1% for student in an organized health care education/training program in TX.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Luu is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (speaking/promotional, top 1%), with 15 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Luu experienced with darbepoetin injection (aranesp) for anemia?
Does Dr. Luu receive payments from pharmaceutical companies?
How do Dr. Luu's costs compare to other student in an organized health care education/training programs in Dallas?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology